Erectile dysfunction — what to add, what to avoid
Erectile dysfunction is mostly a vascular problem — it's the symptom that often shows up before a cardiovascular event does. The supplement stack with credible evidence works on the nitric-oxide pathway (the same target as PDE5 inhibitors approach indirectly) and is reasonable in mild-to-moderate ED while the actual cardiovascular workup happens. Severe or sudden ED is a clinical evaluation, not a supplement-bottle problem.
The supplement layer with credible evidence
L-Citrulline
1.5–3 g/day, taken 1–2 hours before sexual activity (or chronically)
L-citrulline is converted to L-arginine more efficiently than oral L-arginine itself (arginine has poor oral bioavailability due to intestinal arginase). Arginine is the substrate for nitric oxide synthase. Small RCTs (Cormio 2011) show improved erection hardness scores at 1.5 g/day in men with mild ED. Effect is modest, not in the league of PDE5 inhibitors. Reasonable in mild ED, in performance contexts where mild ED occurs intermittently, and as an adjunct in users intolerant of or refusing PDE5 inhibitors.
Korean red ginseng (Panax ginseng)
600–1,000 mg three times daily of standardised extract
Korean red ginseng has multiple small RCTs and a Cochrane review supporting modest improvement in IIEF-5 scores at 600 mg TID for 8–12 weeks. The mechanism likely involves nitric-oxide-mediated vasodilation plus central effects. Effect size is modest. Look for products standardised to ginsenosides (≥10%).
Pycnogenol (pine bark extract)
120 mg/day Pycnogenol + 1.5 g/day L-arginine
The Pycnogenol + L-arginine combination has multiple small trials showing improvement in erectile function scores over 6–12 weeks. The combination outperforms either alone, likely because Pycnogenol upregulates eNOS activity while L-arginine supplies substrate. Reasonable second-line supplement option for mild-moderate ED.
Vitamin D3 (if 25-OH-D is low)
1,000–2,000 IU/day to maintain 25-OH-D in normal range
Vitamin D deficiency correlates observationally with ED severity and with low testosterone. Trial evidence for ED-specific endpoints is modest, but baseline repletion is sensible. Test before chasing higher levels.
The testosterone question
ED in men with low total or free testosterone may improve with testosterone replacement, but testosterone is not first-line for ED in eugonadal men. The "low T" direct-to-consumer marketing has substantially exceeded the clinical reality — most men with ED do not have hypogonadism. Check morning total testosterone (and free T if borderline), discuss with prescriber. Do not self-treat with online testosterone or with "T-boosting" multi-ingredient supplements — most show no effect on serum testosterone, and the few that do (high-dose fenugreek, certain forms of ashwagandha in younger untrained men) produce small effects that don't typically translate into ED improvement.
The PDE5 inhibitor reality
Sildenafil, tadalafil, vardenafil, and avanafil are the most effective ED treatments, with 60–80% response rates across organic ED etiologies. They are now off-patent, generic, and inexpensive — sildenafil 50 mg generic costs $1–3 per dose. The "natural alternatives" supplement market exists largely because of stigma about asking a clinician for them; the supplements with credible evidence have effect sizes in single digits relative to baseline IIEF-5. If supplements at 8–12 weeks have not produced satisfactory improvement, the next step is a PDE5 prescription, not stacking more supplements.
What to skip
- Unregulated "male enhancement" pills sold at gas stations or online — FDA has documented hundreds of these products spiked with sildenafil, tadalafil, or analogues at unknown doses. The interaction with nitrate-containing heart medications can be fatal. Buy from a regulated pharmacy.
- Yohimbe (Pausinystalia johimbe) — alpha-2 adrenoceptor antagonist with documented signal for ED but a significant adverse-event profile (anxiety, hypertension, tachyarrhythmias). Real cardiovascular risk in middle-aged ED users who often have undiagnosed hypertension. Not recommended outside specialist supervision.
- Tongkat Ali, fadogia agrestis, tribulus terrestris — marketed as "T-boosters" or ED helpers; the testosterone signal is small to absent in well-conducted trials and the ED signal is thinner still.
- Horny goat weed (epimedium) — icariin is a weak PDE5 inhibitor in vitro; clinical data in humans is thin and inconsistent.
- "All-in-one ED stacks" with proprietary blends — undeclared spiking is common; dosing transparency is not.
The lifestyle layer that matters more
Smoking cessation, weight loss in the overweight, aerobic exercise, glycemic control in diabetes, blood pressure management, alcohol moderation, and sleep apnea treatment produce ED improvements that supplements do not match. Pelvic floor exercise has small-trial evidence in mild ED. Relationship/psychotherapy elements are real and treatable.